Zepbound™ (tirzepatide)
Operates by activating two hormone receptors (GLP-1 and GIP) to reduce appetite, food intake, body fat, and body weight. Clinical trials have shown significant weight loss across various doses, with some participants achieving over 25% body weight loss.